메뉴 건너뛰기
Gynecologic Oncology
Volumn 69, Issue 2, 1998, Pages 91-92
'Recurrence within 6 months of platinum therapy': An adequate definition of 'platinum-refractory' ovarian cancer?
Author keywords

[No Author keywords available]
Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; PACLITAXEL; PLATINUM DERIVATIVE;
EID: 0031832445     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4997     Document Type: Editorial
Times cited : (44)
References (8)
  • 2
    • 0024589974 scopus 로고
    • Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy
    • DM Gershenson JJ Kavanagh LJ Copeland CA Stringer M Morris JT Wharton Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy Obstet Gynecol 73 1989 798 802
    • (1989) Obstet Gynecol , vol.73 , pp. 798-802
    • Gershenson, DM1    Kavanagh, JJ2    Copeland, LJ3    Stringer, CA4    Morris, M5    Wharton, JT6
  • 3
    • 0025103224 scopus 로고
    • Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds
    • ME Gore I Fryatt E Wiltshaw T Dawson Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds Gynecol Oncol 36 1990 207 211
    • (1990) Gynecol Oncol , vol.36 , pp. 207-211
    • Gore, ME1    Fryatt, I2    Wiltshaw, E3    Dawson, T4
  • 4
    • 0000989020 scopus 로고
    • The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing
    • PJ Hoskins SE O'Reilly KD Swenerton The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing Int J Gynecol Cancer 1 1991 205 208
    • (1991) Int J Gynecol Cancer , vol.1 , pp. 205-208
    • Hoskins, PJ1    O'Reilly, SE2    Swenerton, KD3
  • 5
    • 0031172815 scopus 로고    scopus 로고
    • Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens
    • M Markman A Kennedy K Webster B Kulp G Peterson J Belinson Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens Gynecol Oncol 65 1997 434 436
    • (1997) Gynecol Oncol , vol.65 , pp. 434-436
    • Markman, M1    Kennedy, A2    Webster, K3    Kulp, B4    Peterson, G5    Belinson, J6
  • 6
    • 0026517086 scopus 로고
    • Responses to ‘salvage’ chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population
    • M Markman W Hoskins Responses to ‘salvage’ chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population J Clin Oncol 10 1992 513 514
    • (1992) J Clin Oncol , vol.10 , pp. 513-514
    • Markman, M1    Hoskins, W2
  • 8
    • 0028153230 scopus 로고
    • Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group study
    • JT Thigpen JA Blessing H Ball SJ Hummel RJ Barrett Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group study J Clin Oncol 12 1994 1748 1753
    • (1994) J Clin Oncol , vol.12 , pp. 1748-1753
    • Thigpen, JT1    Blessing, JA2    Ball, H3    Hummel, SJ4    Barrett, RJ5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.